Retinoids and pregnancy: an update
2014
Key content
The use and pharmacokinetics of retinoids.
The main known teratogenic effects of retinoids are face, skull, cardiovascular, nervous system and thymic abnormalities.
The pregnancy prevention programme must be adhered to when initiating retinoid treatment.
Effective contraception should be continued for at least one month after cessation of retinoid treatment.
Management options of pregnant women with recent retinoid use or exposure in early pregnancy; including involvement of the specialist multidisciplinary team.
Learning objectives
To understand the risk and in particular teratogenesis associated with exposure to retinoids peri-conception.
To raise awareness of the pregnancy prevention programme.
To highlight the management options for women who become pregnant with recent retinoid use or exposure in early pregnancy.
Ethical issues
Termination of pregnancy with peri-conceptual exposure to retinoids.
Should isotretinoin be used so widely in the childbearing population when we are aware of its teratogenicity?
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
20
References
15
Citations
NaN
KQI